Filing Details

Accession Number:
0001127602-23-005808
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-02-17 16:02:24
Reporting Period:
2023-02-15
Accepted Time:
2023-02-17 16:02:24
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1100682 Charles River Laboratories International Inc. CRL Services-Commercial Physical & Biological Research (8731) 061397316
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1141722 C James Foster 251 Ballardvale Street
Wilmington MA 01887
Chairman, President And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2023-02-15 19,892 $250.00 216,702 No 4 S Direct
Common Stock Disposition 2023-02-15 108 $250.16 216,594 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 4,328 Indirect 2021 GRAT
Common Stock 11,000 Indirect 2022 GRAT
Common Stock 13,640 Indirect 2020 GRAT
Common Stock 750 Indirect By Trust
Common Stock 340 Indirect By Trust
Common Stock 2,250 Indirect By Trust
Common Stock 10,000 Indirect Held By Spouse
Footnotes
  1. This sale occurred pursuant to a 10b5-1 Trading Plan.
  2. On 2/01/2023: 3,672 shares were transferred from the 2021 GRAT account to Direct Holdings.